Growth hormone response to clonidine predicts aggression in Alzheimer's disease

Psychoneuroendocrinology
Nathan HerrmannLyla R Khan

Abstract

The neurobiology of aggression in Alzheimer's Disease (AD) remains unknown. The objective of this study was to determine if altered central noradrenergic (NE) responsiveness is related to aggression in AD. Fifteen institutionalized, non-depressed elderly (11 males, four females, mean age 81.5 +/- 5.5) with probable AD, severe cognitive impairment (MMSE mean 3.3 +/- 4.6) and significant behavioral disturbances (Neuropsychiatric Inventory (NPI) score > or = 8) were studied. Growth Hormone (GH) response to clonidine challenge (5 microg/kg) was used as an index of central alpha(2)-adrenergic function. When patients were divided into those with preserved GH response (GH maximum change from baseline > 0, n = 6) and those with blunted GH response (GH maximum change from baseline < or = 0, n = 9) there were significant differences in levels of aggression as measured by the Cohen-Mansfield Agitation Inventory (CAMI) physical aggression subscale (p = .026). Patients with blunted GH response also had significantly higher levels of aggression against others on the retrospective Overt Aggression Scale (p = 0.027). Certain types of physically aggressive behaviors are associated with a blunted GH response to clonidine challenge. This finding ...Continue Reading

References

Sep 1, 1975·Archives of Neurology·V C HachinskiL Symon
Oct 1, 1986·Journal of the American Geriatrics Society·J Cohen-Mansfield, N Billig
Sep 1, 1986·Biological Psychiatry·T W UhdeR M Post
Oct 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·I B GlassS Dawling
Sep 1, 1984·Mechanisms of Ageing and Development·I Gil-AdZ Laron
Apr 1, 1984·Archives of General Psychiatry·M A RaskindD C Jimerson
Feb 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·D M MannJ Hawkes
Jul 16, 1982·JAMA : the Journal of the American Medical Association·P V RabinsM J Lucas
Feb 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R MongeauP Blier
Feb 24, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·K L LanctôtP Mazzotta
Mar 21, 2002·Biological Psychiatry·Kim L MatthewsPaul T Francis

❮ Previous
Next ❯

Citations

Aug 19, 2014·BioMed Research International·Xiao-Ling LiLan Tan
Sep 1, 2005·Current Neurology and Neuroscience Reports·Dag AarslandClive Ballard
Mar 2, 2006·Gerontology·Robert T RubinR Kenneth Czambel
Mar 10, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kristina GotovacFran Borovečki
Jun 28, 2011·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Anna LennquistLars Förlin
Jun 26, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Myuri RuthirakuhanNathan Herrmann
May 5, 2018·The Cochrane Database of Systematic Reviews·Myuri T RuthirakuhanKrista L Lanctôt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.